Heterogeneity in outcomes of TP53-mutated myeloproliferative neoplasms based on disease phenotype and mutational status

Related Experiment Video

Updated: May 23, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.5K

Talha Badar1, James M Foran1, Jan Philipp Bewersdorf2,3

  • 1Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, Florida, USA.

British Journal of Haematology
|May 22, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.1K

Related Experiment Videos

Last Updated: May 23, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.5K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.1K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K

Articles linked to this work by shared authors, journal, and citation graph.

Interferon Therapy in Acute Myeloid Leukemia: Biological Rationale, Clinical Evidence, and Future Directions.

Cancers·2026

The speed of sequencing: Rapid molecular testing in acute myeloid leukaemia.

British journal of haematology·2026

Myelodysplastic syndromes/neoplasms presenting with isolated thrombocytopenia: a poorly understood pathophysiology, difficult to diagnose, and challenging to treat entity.

Expert review of anticancer therapy·2026

Impact of Metformin on the Incidence of Thrombosis in Older Adults with Polycythemia Vera or Essential Thrombocythemia and Diabetes.

Blood advances·2026

The SickleFit Tele-Exercise Program for older adults with sickle cell disease: feasibility, acceptability, safety study.

Blood red cells & iron·2026

Clinical and molecular characteristics of clonal monocytosis with and without cytopenia(s).

Leukemia·2026

Ageing and female sex progressively remodel B- and T-cell compartments to strain peripheral T-cell tolerance to red blood cell autoantigens.

British journal of haematology·2026

Second allogeneic haematopoietic stem cell transplantation for non-malignant diseases.

British journal of haematology·2026

Temporal trends in infectious risk among multiple myeloma patients treated with daratumumab: A meta-analysis.

British journal of haematology·2026

Whole-genome and transcriptome analysis in relapsed/refractory non-Hodgkin lymphoma: Results from a multicentre precision oncology cohort.

British journal of haematology·2026

Temporal lobe cortical thickness and cognition in paediatric cancer survivors previously treated with chemotherapy.

British journal of haematology·2026

Thalidomide dose selection for prevention of camrelizumab-induced reactive cutaneous capillary endothelial proliferation: a multicenter, randomized phase II trial.

Frontiers in immunology·2026

Palliative care in hematologic malignancies: a bibliometric review and visualization analysis from 2000 to 2025.

Frontiers in oncology·2026

Clinical Significance of Indeterminate Antibody to Hepatitis C in Cancer Patients.

Journal of viral hepatitis·2026

Clinical Outcomes of Surgical Treatment for Crohn's Disease-Associated Duodenal Fistulas.

World journal of surgery·2026

[Blast morphological abnormalities in de novo acute myeloid leukemia (excluding acute promyelocytic leukemia): associations with genetic alterations and diagnostic value of pseudo-Chediak-Higashi inclusions for the t(8;21) translocation].

Annales de biologie clinique·2026

The impact of leukocyte-associated RNA retention on platelet RNA-based cancer detection.

Molecular oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us